Add
CXM to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| CXM > SEC Filings for CXM > Form 8-K on 4-Nov-2009 | All Recent SEC Filings |
4-Nov-2009
Other Events, Financial Statements and Exhibits
On November 2, 2009, Cardium Therapeutics, Inc. ("Cardium") issued a press release announcing its plans to submit a 510(k) premarket notification with the U.S. Food and Drug Administration (FDA) seeking marketing clearance of its ExcellagenXL™ product candidate. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.
(d) Exhibits.
99.1 Press Release of Cardium issued on November 2, 2009.
|
|